Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users.
OBJECTIVE
The aim of the present study was to measure the treatment of menorrhagia and health-related quality of life (QoL) in Levonorgestrel-releasing intrauterine system (LNG-IUS) in Turkish women.


METHODS
We recruited 66 premenopausal women, aged 26-55 years, who had sought care in the previous year for menorrhagia. All patients were asked to complete a visual analog scale (VAS) form regarding pelvic pain, sexual life (libido) and general feeling of health. Patients filled the VAS form before LNG-IUS insertion and after 6 months.


RESULTS
After the 6-month visit, PBAC score was condirebly decreased (p < 0.001). Six (10%) of the 60 patients PBAC score was higher than 75. VAS score for pelvic pain decreased from baseline to 6-month follow-up (4.32-3.55), and the libido and general feeling of health increased (4.27-4.95 and 3.47-6.87, respectively).


CONCLUSIONS
The LNG-IUS device in the trearment of menorrhagia has cost effective, less side effects and increse in the QoL.
Gorgen
Husnu
H
Department of Obstetrics and Gynecology, Haseki Education and Research Hospital, Istanbul, Turkey. husnugorgen@yahoo.com
Api
Murat
M
Akça
Aysu
A
Cetin
Ahmet
A
D000328:Adult; D003280:Contraceptives, Oral, Synthetic / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated; D016912:Levonorgestrel / Q000008:administration & dosage; D008595:Menorrhagia / Q000628:therapy*; D008875:Middle Aged; D011788:Quality of Life; D014421:Turkey
D003280:Contraceptives, Oral, Synthetic; D016912:Levonorgestrel